Hi All,
My Father was diagnosed with Advanced PCa with extensive bone mets but no visceral spread last November. His PSA at dx was 325 and Gleason was 4+5 with all cores positive.
His treatment started off with 10 sessions of Palliative RT followed by combination of Degarelix + Enzaluatmide + Denosumab repeating every 28 days. He has been on this regimen till date
His condition has visibly improved over the year but PSA hasn't dropped to undetectable levels as we had hoped initially. His PSA readings since treatment have been :-
12/21 - 4.1
3/22 - 2.29
5/22- 0.99
7/22 - 1.17
8/22 - 1.03
10/22 - 0.94
Apparently his PSA Nadir seems to be settling around 1 . I have gone through a lot of articles that suggest that lower PSA Nadir (preferably undetectable) has better prognostic value. Was wondering if adding Docetaxel to the regimen is desirable here ?
Our Oncologist says that while he would have liked the PSA to drop to undetectable levels he is not overly worried about the PSA trend , he wants to reserve chemo for future use when PSA starts rising with a clear trend, till such time he wants to continue with the existing combination
Is this ok or should we insist on adding Docetaxel as recent articles seem to suggest that Triplet Therapy offers better OS benifits ?
Thanks & Regards